Multiple Myeloma Hub

57 Episodes

1. Managing infections with novel immunotherapies: Prevention, treatment, and impact on the QoL of patients with MM

   Published: 11/9/2021
2. Should 'cure' be the goal for multiple myeloma?

   Published: 10/14/2021
3. Treating elderly and frail patients with MM: Cure versus disease control

   Published: 10/7/2021
4. Is transplantation still relevant? If yes, in what context?

   Published: 9/30/2021
5. The challenges of monitoring organ response in AL amyloidosis: What has been achieved so far?

   Published: 9/24/2021
6. Is the treatment of high-risk SMM the way for achieving the cure?

   Published: 9/23/2021
7. Does 'cure' have a different meaning in MM?

   Published: 9/15/2021
8. How to treat first relapse in lenalidomide-refractory MM?

   Published: 7/19/2021
9. With the unprecedented results seen with novel therapies, what is needed to overcome the poor prognosis of high-risk MM?

   Published: 6/30/2021
10. When BCMA-directed therapy is not an option, how should we treat late relapse?

    Published: 5/24/2021
11. What do you need to remember when facing CAR T-cell toxicities?

    Published: 4/12/2021
12. What are the key additions to the new NCCN guidelines for multiple myeloma?

    Published: 4/7/2021
13. If maintenance after induction reduces therapy options at relapse, is it still worth it?

    Published: 4/1/2021
14. New findings on the role of the immune microenvironment presented at ASH 2020

    Published: 2/16/2021
15. ASH 2020 discussion: Looking for the best partner for lenalidomide maintenance after auto-SCT

    Published: 2/9/2021
16. Should we still use high-dose melphalan in the era of novel agents?

    Published: 2/9/2021
17. What are the unmet needs in AL amyloidosis in Europe?

    Published: 2/1/2021
18. ASH 2020 discussion: The role of upfront transplant consolidation in the era of novel agents

    Published: 1/27/2021
19. Can single cell sequencing help to better define and monitor MM?

    Published: 12/17/2020
20. My experience with novel immunotherapies

    Published: 11/11/2020